Abstract
Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / pharmacology
-
Bacteremia / complications
-
Bacteremia / diagnosis*
-
Bacteremia / drug therapy
-
Betaproteobacteria / isolation & purification*
-
Burkholderia Infections / complications
-
Burkholderia Infections / diagnosis*
-
Burkholderia Infections / drug therapy
-
Cystic Fibrosis / complications
-
Cystic Fibrosis / diagnosis*
-
Drug Therapy, Combination / therapeutic use
-
Follow-Up Studies
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Respiratory Tract Infections / complications
-
Respiratory Tract Infections / drug therapy
-
Respiratory Tract Infections / microbiology*
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome